Thermo fisher scientific leverages integrated solutions to accelerate the development of biologic therapeutics

Waltham, mass.--(business wire)--thermo fisher scientific, the world leader in serving science, is employing an enhanced platform technology and a new cho k-1 cell line that can reduce timelines to investigational new drug (ind) filing from 13 to nine months, helping biotech and pharmaceutical companies overcome logistical complexities within pre-clinical biologic drug development. the new cho k-1 cell line is able to deliver up to 8g/l, providing higher protein expression levels and increased.
TMO Ratings Summary
TMO Quant Ranking